Small Intestinal Bacterial Overgrowth: A Prospective Registry

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Indiana University
Study ID
NCT01822470
Status
Enrolling By Invitation

Conditions

  • Functional Dyspepsia
  • Small Intestinal Bacterial Overgrowth

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to investigate the prevalence of small intestinal bacterial overgrowth (SIBO) in patients who will be undergoing an enteroscopy as an outpatient procedure with symptoms of functional dyspepsia. In addition, the investigators would like to identify the types of bacteria that are present in the small intestines in patients with SIBO and compare two different diagnostic tools: microbiologic culture and DNA sequencing of bacteria. The aim is to compare the microbiota between patients with and without the clinical complications of SIBO

Key Dates

Start date
Jan 7, 2013
Status verified
Aug 2024
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Study group
    a. Study Subjects will be recruited from patients who are already undergoing upper enteroscopy and aspiration for diagnosis of SIBO.
  • Arm: Control group
    b. Control Subjects will be recruited from patients who are already undergoing a double balloon enteroscopy or upper enteroscopy for another medical reason

Primary Outcome Measure

To determine the predictors for SIBO in patients with functional dyspepsia, who do not have the established risk factors for SIBO [ Time Frame: two years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Indiana University HospitalIndianapolisIndiana46202-

Find similar trials in Indianapolis, IN

By research site
Indiana University Hospital· Indianapolis, IN

Related Studies